HIGHLIGHTS
- who: Quentin Seisel and collaborators from the University of Montpellier, INSERM, CNRS UMR , have published the Article: Highway to Cell: Selection of the Best Cell-Penetrating Peptide to Internalize the CFTR-Stabilizing iCAL36 Peptide, in the Journal: Pharmaceutics 2022, x of /2022/
- what: The authors aimed to find out the most suitable CPP for the iCAL36 delivery in human epithelial_cells.
- how: The authors selected several different CPPs which were conjugated to the N-terminus of iCAL36. One-way or two-way analysis of variance (ANOVA) with the Bonferroni test was used to compare . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.